Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Published:2015-02-23 Issue:11 Volume:21 Page:2520-2529
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Ock Chan-Young,Lee Keun-Wook,Kim Jin Won,Kim Jin-Soo,Kim Tae-Yong,Lee Kyung-Hun,Han Sae-Won,Im Seock-Ah,Kim Tae-You,Kim Woo Ho,Bang Yung-Jue,Oh Do-Youn

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification;Frontiers in Oncology;2023-06-07

2. Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma;Cancer Medicine;2023-04-29

3. Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma;European Journal of Cancer;2023-04

4. Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination;Journal of Gastric Cancer;2023

5. The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy;Therapeutic Advances in Medical Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP